Enz A, Donatsch P, Nordmann R
J Neural Transm. 1984;60(3-4):225-38. doi: 10.1007/BF01249095.
Mesulergine, an 8-alpha-aminoergoline, is now proven to be of utility in the clinic as an antiparkinsonian drug. However, the molecule itself shows in vitro and in vivo antidopaminergic properties. Mesulergine is rapidly metabolized into several pharmacologically active DA agonists. The influence of mesulergine on central DA metabolism in rats is dependent on the route of drug administration. It was possible to determine the different metabolites of this drug in plasma as well as in rat striatum. A correlation between the actual present concentration of the parent drug and DAergic metabolites and the net action on striatal DA metabolism was found. It may be concluded that mesulergine itself lacks DAergic activity but occupies DA receptors and is very rapidly metabolized into potent DA agonists.
美舒麦角,一种8-α-氨基麦角灵,现已被证明在临床上作为抗帕金森病药物具有效用。然而,该分子本身在体外和体内均表现出抗多巴胺能特性。美舒麦角迅速代谢为几种具有药理活性的多巴胺激动剂。美舒麦角对大鼠中枢多巴胺代谢的影响取决于给药途径。有可能确定该药物在血浆以及大鼠纹状体中的不同代谢产物。发现母体药物和多巴胺能代谢产物的实际现有浓度与对纹状体多巴胺代谢的净作用之间存在相关性。可以得出结论,美舒麦角本身缺乏多巴胺能活性,但占据多巴胺受体,并迅速代谢为强效多巴胺激动剂。